Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 2321 to 2330 of 2382
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction
IPG653
26 June 2019
26 June 2019
Vandetanib for treating medullary thyroid cancer
TA550
12 December 2018
12 December 2018
Varenicline for smoking cessation
TA123
25 July 2007
25 July 2007
Varicose veins in the legs
QS67
14 August 2014
14 August 2014
Varicose veins: diagnosis and management
CG168
24 July 2013
24 July 2013
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
TA352
26 August 2015
26 August 2015
Vedolizumab for treating moderately to severely active ulcerative colitis
TA342
5 June 2015
5 June 2015
Velmanase alfa for treating alpha-mannosidosis
HST29
13 December 2023
13 December 2023
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma
TA269
12 December 2012
1 January 2015
Previous page
1
…
231
232
Current page
233
234
235
…
239
Page
233
of
239
Next page
Results per page
10
25
50
All
Back to top